Tapewire

Nasdaq · USD

NVCR

NovoCure Ltd

Export transactions ↓
Tapewire entity
4494
SEC CIK
0001645113
Parsed reports
725

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202605
Mar 2026012
Apr 202600
May 202600
Jun 202608
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 13, 2017 Filed Nov 14, 2017 16:25 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 30,000 $17.13 $513,870.00
Disclosure

SEC source: 0001209191-17-060601 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,431,054

F1 · price: On November 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $16.925 to $17.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 10, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 3,900 $18.04 $70,356.00
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 6

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,461,054

F7 · price: On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 3,900 shares in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 10, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 26,100 $17.54 $457,794.00
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 5

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,464,954

F6 · price: On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 26,100 shares in multiple trades at prices ranging from $17.20 to $17.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 09, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 5,388 $18.74 $100,971.12
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 4

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,491,054

F5 · price: On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 5,388 shares in multiple trades at prices ranging from $18.65 to $19.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 09, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 24,612 $18.14 $446,461.68
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 3

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,496,442

F4 · price: On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 24,612 shares in multiple trades at prices ranging from $17.65 to $18.625. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 08, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 6,266 $20.17 $126,385.22
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,521,054

F3 · price: On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,266 shares in multiple trades at prices ranging from $20.00 to $20.50. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 08, 2017 Filed Nov 13, 2017 16:36 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 23,734 $19.46 $461,863.64
Disclosure

SEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,527,320

F1 · price: On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 23,734 shares in multiple trades at prices ranging from $19.10 to $19.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 07, 2017 Filed Nov 8, 2017 16:17 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 2,900 $21.14 $61,306.00
Disclosure

SEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 3

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,551,054

F4 · price: On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,900 shares in multiple trades at prices ranging from $20.975 to $21.40. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 07, 2017 Filed Nov 8, 2017 16:17 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 27,100 $20.34 $551,214.00
Disclosure

SEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,553,954

F3 · price: On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,100 shares in multiple trades at prices ranging from $19.90 to $20.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 16:17 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 30,000 $21.71 $651,240.00
Disclosure

SEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,581,054

F1 · price: On November 6, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.45 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 16:15 UTC
Kirson Eilon D.Chief Science Officer
SaleOrdinary Shares 9,100 $22.00 $200,200.00
Disclosure

SEC source: 0001209191-17-059742 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,501

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:14 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 6,919 $22.00 $152,218.00
Disclosure

SEC source: 0001209191-17-059740 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 749,105

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

Read SEC document
November 03, 2017 Filed Nov 6, 2017 16:18 UTC
Kirson Eilon D.Chief Science Officer
SaleOrdinary Shares 3,100 $22.00 $68,200.00
Disclosure

SEC source: 0001209191-17-059404 · doc4.xml · nonDerivative · entry 2

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,601

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.

Read SEC document
November 03, 2017 Filed Nov 6, 2017 16:17 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 900 $22.00 $19,800.00
Disclosure

SEC source: 0001209191-17-059403 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,087

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

Read SEC document
November 03, 2017 Filed Nov 6, 2017 16:22 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 30,000 $21.66 $649,680.00
Disclosure

SEC source: 0001209191-17-059405 · doc4.xml · nonDerivative · entry 2

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,611,054

F3 · price: On November 3, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.35 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 03, 2017 Filed Nov 6, 2017 21:15 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 2,300 $22.00 $50,600.00
Disclosure

SEC source: 0001209191-17-059400 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,024

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

Read SEC document
November 02, 2017 Filed Nov 6, 2017 16:18 UTC
Kirson Eilon D.Chief Science Officer
SaleOrdinary Shares 300 $22.00 $6,600.00
Disclosure

SEC source: 0001209191-17-059404 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,701

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.

Read SEC document
November 02, 2017 Filed Nov 6, 2017 16:17 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 300 $22.00 $6,600.00
Disclosure

SEC source: 0001209191-17-059403 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,987

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

Read SEC document
November 02, 2017 Filed Nov 6, 2017 16:22 UTC
Palti YoramDirector · Chief Technology Officer
SaleOrdinary Shares 30,000 $21.78 $653,520.00
Disclosure

SEC source: 0001209191-17-059405 · doc4.xml · nonDerivative · entry 1

Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Bennett Limited

Disclosed balance after: 1,641,054

F1 · price: On November 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.50 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

Read SEC document
November 01, 2017 Filed Nov 2, 2017 16:22 UTC
Kirson Eilon D.Chief Science Officer
SaleOrdinary Shares 22,119 $22.01 $486,810.44
Disclosure

SEC source: 0001209191-17-058849 · doc4.xml · nonDerivative · entry 2

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,001

F2 · price: On November 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 22,119 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 01, 2017 Filed Nov 2, 2017 16:19 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 24,227 $22.01 $533,163.59
Disclosure

SEC source: 0001209191-17-058834 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,287

F2 · price: On November 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 24,227 shares in multiple trades at prices ranging from $22.00 to $22.075. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 01, 2017 Filed Nov 2, 2017 20:20 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 15,716 $22.01 $345,869.87
Disclosure

SEC source: 0001209191-17-058842 · doc4.xml · nonDerivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 758,324

F2 · price: On November 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 15,716 shares in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 31, 2017 Filed Nov 2, 2017 16:22 UTC
Kirson Eilon D.Chief Science Officer
SaleOrdinary Shares 150 $22.00 $3,300.00
Disclosure

SEC source: 0001209191-17-058849 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,120

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.

Read SEC document
October 31, 2017 Filed Nov 2, 2017 16:19 UTC
Ambrogi Michael J.Chief Operating Officer
SaleOrdinary Shares 100 $22.00 $2,200.00
Disclosure

SEC source: 0001209191-17-058834 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,514

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

Read SEC document
October 31, 2017 Filed Nov 2, 2017 20:20 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 150 $22.00 $3,300.00
Disclosure

SEC source: 0001209191-17-058842 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 774,040

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 16:19 UTC
Kirson Eilon D.Chief Science Officer
Disposition to issuerOrdinary Shares 1,900 $22.03 $41,864.98
Disclosure

SEC source: 0001209191-17-054126 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,270

F1 · price: On September 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,900 shares in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 16:16 UTC
Ambrogi Michael J.Chief Operating Officer
Disposition to issuerOrdinary Shares 3,200 $22.05 $70,554.88
Disclosure

SEC source: 0001209191-17-054124 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,614

F1 · price: On September 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,200 shares in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 20:18 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 900 $22.05 $19,845.00
Disclosure

SEC source: 0001209191-17-054125 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 774,190

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 16:23 UTC
Ambrogi Michael J.Chief Operating Officer
Disposition to issuerOrdinary Shares 3,200 $22.00 $70,400.00
Disclosure

SEC source: 0001209191-17-053605 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,814

F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 16:09 UTC
Kirson Eilon D.Chief Science Officer
Disposition to issuerOrdinary Shares 2,500 $22.03 $55,080.00
Disclosure

SEC source: 0001209191-17-052952 · doc4.xml · nonDerivative · entry 2

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,170

F2 · price: On September 14, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 2,500 shares in multiple trades at prices ranging from $22.00 to $22.25. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 16:04 UTC
Ambrogi Michael J.Chief Operating Officer
Disposition to issuerOrdinary Shares 1,746 $22.00 $38,417.06
Disclosure

SEC source: 0001209191-17-052948 · doc4.xml · nonDerivative · entry 2

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,014

F2 · price: On September 14, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,746 shares in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 20:05 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 1,772 $22.00 $38,984.00
Disclosure

SEC source: 0001209191-17-052951 · doc4.xml · nonDerivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 775,090

Read SEC document
September 13, 2017 Filed Sep 15, 2017 16:09 UTC
Kirson Eilon D.Chief Science Officer
Disposition to issuerOrdinary Shares 46,872 $22.01 $1,031,765.21
Disclosure

SEC source: 0001209191-17-052952 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,670

F1 · price: On September 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 46,872 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 16:04 UTC
Ambrogi Michael J.Chief Operating Officer
Disposition to issuerOrdinary Shares 76,327 $22.02 $1,680,522.09
Disclosure

SEC source: 0001209191-17-052948 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,760

F1 · price: On September 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 76,327 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:05 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 35,500 $22.01 $781,518.30
Disclosure

SEC source: 0001209191-17-052951 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 776,862

F1 · price: On September 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 35,500 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:48 UTC
Danziger AsafDirector · Chief Executive Officer
Exercise / conversionOptions to Buy Ordinary Shares · Derivative 354,780 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001209191-17-045514 · doc4.xml · derivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 354,780 shares

Expires 2020-10-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested and currently exercisable as of the date hereof.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:48 UTC
Danziger AsafDirector · Chief Executive Officer
Exercise / conversionOrdinary Shares 354,780 $0.38 $134,816.40
Disclosure

SEC source: 0001209191-17-045514 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 812,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2017 Filed Jul 13, 2017 20:14 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 5,183 $20.19 $104,644.77
Disclosure

SEC source: 0001209191-17-045037 · doc4.xml · nonDerivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457,582

F2 · price: On July 11, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 5,183 shares in multiple trades at prices ranging from $19.80 to $20.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 11, 2017 Filed Jul 13, 2017 20:14 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 2,200 $19.40 $42,680.00
Disclosure

SEC source: 0001209191-17-045037 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 462,765

F1 · price: On July 11, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 2,200 shares in multiple trades at prices ranging from $18.80 to $19.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 10, 2017 Filed Jul 11, 2017 20:22 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 203,900 $18.08 $3,685,900.30
Disclosure

SEC source: 0001209191-17-044773 · doc4.xml · nonDerivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 464,965

F2 · price: On July 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 203,900 shares in multiple trades at prices ranging from $18.00 to $18.25. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 07, 2017 Filed Jul 11, 2017 20:22 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 70,459 $18.03 $1,270,657.61
Disclosure

SEC source: 0001209191-17-044773 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 668,865

F1 · price: On July 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 70,459 shares in multiple trades at prices ranging from $18.00 to $18.15. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 06, 2017 Filed Jul 7, 2017 20:33 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 5,050 $18.09 $91,344.40
Disclosure

SEC source: 0001209191-17-044389 · doc4.xml · nonDerivative · entry 3

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 739,324

F4 · price: On July 6, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 5,050 shares in multiple trades at prices ranging from $18.00 to $18.20. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 16:48 UTC GrantOrdinary Shares 2,810 $6.67 $18,751.13
Disclosure

SEC source: 0001209191-17-044407 · doc4.xml · nonDerivative · entry 1

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,832

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2017 through June 30, 2017. This transaction is also exempt under Rule 16b-3(c).

F2 · shares: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 16:40 UTC
Kirson Eilon D.Chief Science Officer
Disposition to issuerOrdinary Shares 111,361 $18.14 $2,020,533.98
Disclosure

SEC source: 0001209191-17-044395 · doc4.xml · nonDerivative · entry 2

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,542

F3 · price: On July 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 111,361 shares in multiple trades at prices ranging from $18.00 to $18.35. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 16:40 UTC
Kirson Eilon D.Chief Science Officer
GrantOrdinary Shares 3,181 $6.67 $21,226.81
Disclosure

SEC source: 0001209191-17-044395 · doc4.xml · nonDerivative · entry 1

Kirson Eilon D. · CIK 0001654356 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,903

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2017 through June 30, 2017. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 16:43 UTC
Ambrogi Michael J.Chief Operating Officer
GrantOrdinary Shares 1,395 $6.67 $9,308.84
Disclosure

SEC source: 0001209191-17-044402 · doc4.xml · nonDerivative · entry 1

Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,087

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2017 through June 30, 2017. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 20:46 UTC
GROENHUYSEN WILHELMUS CMChief Financial Officer
GrantOrdinary Shares 2,484 $6.67 $16,575.73
Disclosure

SEC source: 0001209191-17-044405 · doc4.xml · nonDerivative · entry 1

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,768

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2017 through June 30, 2017. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 20:33 UTC
Danziger AsafDirector · Chief Executive Officer
SaleOrdinary Shares 155,088 $18.14 $2,813,916.67
Disclosure

SEC source: 0001209191-17-044389 · doc4.xml · nonDerivative · entry 2

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 744,374

F3 · price: On July 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 155,088 shares in multiple trades at prices ranging from $18.00 to $18.35. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 05, 2017 Filed Jul 7, 2017 20:33 UTC
Danziger AsafDirector · Chief Executive Officer
GrantOrdinary Shares 2,545 $6.67 $16,982.79
Disclosure

SEC source: 0001209191-17-044389 · doc4.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 899,462

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2017 through June 30, 2017. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017.

Read SEC document
June 26, 2017 Filed Jun 27, 2017 16:11 UTC
JANIS FRANCES10% owner
FUTRELL STEVE10% owner
SaleCommon Stock 30,945 $17.46 $540,203.77
Disclosure

SEC source: 0001012975-17-000497 · edgar.xml · nonDerivative · entry 4

Pomona Capital VII, L.P. · CIK 0001701202 · 10% owner

Pomona Capital VII Fund Investors, L.P. · CIK 0001701201 · 10% owner

Pomona Associates VII, L.P. · CIK 0001701204 · 10% owner

Pomona Secondary Associates VII LLC · CIK 0001700911 · 10% owner

Pomona G.P. Holdings LLC · CIK 0001700910 · 10% owner

GRANOFF MICHAEL D · CIK 0001639347 · 10% owner

JANIS FRANCES · CIK 0001639491 · 10% owner

FUTRELL STEVE · CIK 0001639633 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,741,925

F4 · price: The transaction was executed in multiple trades at prices ranging from $17.10 to $17.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.

F3 · ownership.direct: The shares are held directly by Pomona Capital VII Fund Investors, L.P. ("PC VII FI"). The Class A general partner of PC VII FI is PCVII GP and the Class B general partner of PC VII FI is PCVII LLC. The general partner of PCVII GP is also PCVII LLC. The sole member of PCVII LLC is Holdings LLC. The individual managers of Holdings LLC are Granoff, Janis and Futrell and, as such, each of PCVII GP, PCVII LLC, Holdings LLC, Granoff, Janis and Futrell exercises shared voting and investment power over the shares held of record by PC VII FI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.